Daily Dividend Update: NKE, UGI, WNC, HD, KMB
NIKE Dividend Announcement: NIKE's Board of Directors declared a quarterly cash dividend of $0.41 per share, marking a 3% increase from the previous rate, and continuing a 24-year trend of dividend increases.
UGI Dividend Declaration: UGI's Board announced a quarterly dividend of $0.375 per share, payable on January 1, 2026, to shareholders of record by December 15, 2025.
Wabash Quarterly Dividend: Wabash declared a regular quarterly dividend of $0.08 per share, set to be paid on January 29, 2026, to stockholders of record on January 8, 2026.
Home Depot and Kimberly-Clark Dividends: Home Depot declared a quarterly dividend of $2.30 per share, while Kimberly-Clark announced a dividend of $1.26 per share, both reflecting their long-standing commitment to returning value to shareholders.
Trade with 70% Backtested Accuracy
Analyst Views on KMB
About KMB
About the author

Kimberly-Clark and Kenvue Merger Approved by Shareholders
- Merger Approval: The merger between Kimberly-Clark (KMB) and Kenvue (KVUE) received overwhelming shareholder approval, with the transaction expected to close in the second half of 2026, marking a strategic consolidation of two major players in consumer health and personal care.
- Transaction Valuation: The cash-and-stock deal is valued at approximately $48.7 billion, with Kenvue shareholders set to receive $3.50 in cash plus 0.14625 shares of Kimberly-Clark per Kenvue share, ensuring shareholder interests are protected.
- Market Leadership: Post-merger, Kimberly-Clark shareholders will own about 54% of the combined entity, while Kenvue shareholders will hold approximately 46%, positioning the new company as a projected $32 billion leader in health and wellness, serving nearly half of the global population.
- Brand Integration Strategy: The merger combines Kimberly-Clark's tissue, baby, and personal care products with Kenvue's over-the-counter and consumer health brands, enhancing competitive strength in health, hygiene, and skincare markets.

Kimberly-Clark's Acquisition of Kenvue Receives Shareholder Approval
- Shareholder Voting Results: Approximately 96% of Kimberly-Clark shareholders voted in favor of the acquisition of Kenvue at the Special Meeting, reflecting strong confidence in the merger and expected to enhance the company's leadership in global health and wellness.
- Transaction Timeline: The deal is anticipated to close in the second half of 2026, pending regulatory approvals and other customary conditions, with successful integration projected to create significant shareholder value and enhance market competitiveness.
- Integration Planning Progress: Kimberly-Clark and Kenvue leadership teams are actively collaborating on integration planning, aiming to accelerate innovation and expand brand influence, thereby enhancing customer satisfaction and loyalty.
- Optimistic Market Outlook: Kenvue's CEO stated that the merger will accelerate innovation and expand market reach, expected to provide more trusted brands to global consumers, further solidifying both companies' positions in the health and wellness sector.






